Activated Factor Seven in Traumatic Retro Peritoneal Hematoma

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

May 5, 2017

Primary Completion Date

December 19, 2019

Study Completion Date

December 30, 2019

Conditions
Traumatic Bleeding
Interventions
DEVICE

ventilators

all patients in both groups will be ventilated if shocked and no recordable blood pressure

DRUG

aminocaproic acid

4 gram slowly intravenous infusion over 1 hour and continues slowly intravenous infusion 1 gram/ hour for 8 hours.

DRUG

Novo Seven

200 microgram/kg. If patient still oozing, vital data not stable and/or could not achieve and keep the target Hb (\>10 gm%) another 2 doses of aFVII received

Trial Locations (1)

21944

King abd el Aziz specialist hospital, Ta'if

All Listed Sponsors
lead

King Abdul Aziz Specialist Hospital

NETWORK

NCT04424563 - Activated Factor Seven in Traumatic Retro Peritoneal Hematoma | Biotech Hunter | Biotech Hunter